Related Experiment Video
Updated: Sep 9, 2025

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
Is It Scientifically Possible To 'Cure" Reward Deficiency Syndrome (RDS) Via Transplice Molecular Genetic Technology?
Kenneth Blum1,2,3,4, Alireza Sharafshah5, Kai -Uwe-Lewandowski4,6
1Division of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University Health Sciences, Pomona, CA, USA.
Abstract:
In 1995, Kenneth Blum coined the term "Reward Deficiency Syndrome'(RDS) to provide the mental health field with an umbrella term expressing a dissatisfaction of everyday experiences due to a dysregulation of dopaminergic dysregulation especially the DRD2 Taq A1 polymorphism presenting with up to a 40% reduction of D2 receptors in brain tissue with two copies. While the concept of RDS as the actual real umbrella of all mental illness unlike the current DSM-V (the brain is not carved out as portrayed by this important psychiatric manual) awaits further intensive research. In fact, Steven Hyman (former director of NIMH) suggests otherwise and has urged for research related to etiological causes instead to help explain the failings of mental health. Certainly, the RDS Consortium agrees with this difficult but needed psychiatric challenge. It is noteworthy that as of 2-5-2025, there are 1615 articles listed PUBMED using the word term "Reward Deficiency" and 270 listed for RDS specifically. However, since the initial finding of the first gene discovered to associate with severe alcoholism being the DRD2A1 allele by Blum and Noble and their associates, at least 700 or more genes have been found to be involved in RDS behaviors. While this seems quite complex in a study submitted for publication elsewhere deep silico GWAS meta-meta-analysis and pharmacogenomics mining has filtered the actual gene network down to 29 as a predictive panel of RDS behaviors. However, only 15 of these genes are linked into a network and five of these genes include DRD2, DRD4, OPRMI, COMT and 5-HTTLR. Understanding the relevance of a shared genetic basis for mental illness the RDS consortium is developing novel technology to scientifically "cure" RDS via gene editing technology (e.g. Transplice molecular genetic technology). Certainly, the jury is not in as yet, but we are encouraged about the future following arduous research from the scientific community requiring "all hands on deck".
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
CRISPR
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...

